LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2023. The put-call ratio across all filers is 11.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $236,000 | -32.0% | 100,000 | 0.0% | 0.05% | -42.5% |
| Q4 2022 | $347,000 | -52.7% | 100,000 | 0.0% | 0.08% | -52.4% |
| Q3 2022 | $733,000 | +12.4% | 100,000 | 0.0% | 0.17% | +10.5% |
| Q2 2022 | $652,000 | +29.1% | 100,000 | 0.0% | 0.15% | +22.6% |
| Q1 2022 | $505,000 | -34.8% | 100,000 | 0.0% | 0.12% | -34.4% |
| Q4 2021 | $774,000 | -47.7% | 100,000 | 0.0% | 0.19% | -59.7% |
| Q3 2021 | $1,480,000 | -8.9% | 100,000 | 0.0% | 0.47% | -15.8% |
| Q2 2021 | $1,624,000 | – | 100,000 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WuXi AppTec Co., Ltd. | 7,682,156 | $11,139,126 | 47.74% |
| MWG Management Ltd. | 20,162,332 | $29,235,381 | 31.93% |
| Orland Properties Ltd | 15,093,969 | $21,886,255 | 16.63% |
| Foresite Capital Management IV, LLC | 8,325,000 | $12,071,250 | 8.11% |
| Opaleye Management Inc. | 1,670,000 | $2,421,500 | 0.55% |
| MIC Capital Management UK LLP | 1,740,569 | $2,523,825 | 0.55% |
| Alphabet Inc. | 5,865,125 | $8,504,431 | 0.43% |
| HSG Holding Ltd | 3,045,997 | $4,995,435 | 0.18% |
| Orbimed Advisors | 6,405,098 | $9,287,392 | 0.18% |
| Ikarian Capital, LLC | 526,066 | $762,796 | 0.13% |